Eli Lilly and CompanyLLYNYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank71
3Y CAGR-5.6%
5Y CAGR+12.4%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
-5.6%/yr
vs +10.9%/yr prior
5Y CAGR
+12.4%/yr
Recent deceleration
Acceleration
-16.5pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 46.76 | -28.8% |
| 2024 | 65.65 | -34.4% |
| 2023 | 100.04 | +79.7% |
| 2022 | 55.66 | +18.0% |
| 2021 | 47.19 | +81.0% |
| 2020 | 26.08 | +72.4% |
| 2019 | 15.13 | -58.9% |
| 2018 | 36.80 | +108.5% |
| 2017 | -435.34 | -1571.9% |
| 2016 | 29.58 | - |